These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 8821090)
21. Contrasting effects of VEGF gene disruption in embryonic stem cell-derived versus oncogene-induced tumors. Viloria-Petit A; Miquerol L; Yu JL; Gertsenstein M; Sheehan C; May L; Henkin J; Lobe C; Nagy A; Kerbel RS; Rak J EMBO J; 2003 Aug; 22(16):4091-102. PubMed ID: 12912908 [TBL] [Abstract][Full Text] [Related]
22. Different regulation of vascular endothelial growth factor expression by the ERK and p38 kinase pathways in v-ras, v-raf, and v-myc transformed cells. Okajima E; Thorgeirsson UP Biochem Biophys Res Commun; 2000 Apr; 270(1):108-11. PubMed ID: 10733912 [TBL] [Abstract][Full Text] [Related]
23. The K-ras gene regulates vascular endothelial growth factor gene expression in non-small cell lung cancers. Konishi T; Huang CL; Adachi M; Taki T; Inufusa H; Kodama K; Kohno N; Miyake M Int J Oncol; 2000 Mar; 16(3):501-11. PubMed ID: 10675482 [TBL] [Abstract][Full Text] [Related]
24. 'Accidental' anti-angiogenic drugs. anti-oncogene directed signal transduction inhibitors and conventional chemotherapeutic agents as examples. Kerbel RS; Viloria-Petit A; Klement G; Rak J Eur J Cancer; 2000 Jun; 36(10):1248-57. PubMed ID: 10882863 [TBL] [Abstract][Full Text] [Related]
25. A critical role for ras-mediated, epidermal growth factor receptor-dependent angiogenesis in mouse skin carcinogenesis. Casanova ML; Larcher F; Casanova B; Murillas R; Fernández-Aceñero MJ; Villanueva C; Martínez-Palacio J; Ullrich A; Conti CJ; Jorcano JL Cancer Res; 2002 Jun; 62(12):3402-7. PubMed ID: 12067982 [TBL] [Abstract][Full Text] [Related]
26. Signal transduction pathways activated and required for mammary carcinogenesis in response to specific oncogenes. Amundadottir LT; Leder P Oncogene; 1998 Feb; 16(6):737-46. PubMed ID: 9488037 [TBL] [Abstract][Full Text] [Related]
27. Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor. Zhao Y; Adjei AA Oncologist; 2015 Jun; 20(6):660-73. PubMed ID: 26001391 [TBL] [Abstract][Full Text] [Related]
29. Early induction of angiogenetic signals in gliomas of GFAP-v-src transgenic mice. Theurillat JP; Hainfellner J; Maddalena A; Weissenberger J; Aguzzi A Am J Pathol; 1999 Feb; 154(2):581-90. PubMed ID: 10027415 [TBL] [Abstract][Full Text] [Related]
30. Ras regulation of vascular endothelial growth factor and angiogenesis. Rak J; Kerbel RS Methods Enzymol; 2001; 333():267-83. PubMed ID: 11400342 [TBL] [Abstract][Full Text] [Related]
31. Alternative effects of RAS and RAF oncogenes on the proliferation and apoptosis of factor-dependent FDC-P1 cells. McGlynn AP; Padua RA; Burnett AK; Darley RL Leuk Res; 2000 Jan; 24(1):47-54. PubMed ID: 10634645 [TBL] [Abstract][Full Text] [Related]
32. Tumor angiogenesis and anti-angiogenic therapies. Shahneh FZ; Baradaran B; Zamani F; Aghebati-Maleki L Hum Antibodies; 2013; 22(1-2):15-9. PubMed ID: 24284305 [TBL] [Abstract][Full Text] [Related]
33. Role of Oncogenes and Tumor-suppressor Genes in Carcinogenesis: A Review. Kontomanolis EN; Koutras A; Syllaios A; Schizas D; Mastoraki A; Garmpis N; Diakosavvas M; Angelou K; Tsatsaris G; Pagkalos A; Ntounis T; Fasoulakis Z Anticancer Res; 2020 Nov; 40(11):6009-6015. PubMed ID: 33109539 [TBL] [Abstract][Full Text] [Related]
34. Comparative expression of novel vascular endothelial growth factor/vascular permeability factor transcripts in skin, papillomas, and carcinomas of v-Ha-ras Tg.AC transgenic mice and FVB/N mice. Tober KL; Cannon RE; Spalding JW; Oberyszyn TM; Parrett ML; Rackoff AI; Oberyszyn AS; Tennant RW; Robertson FM Biochem Biophys Res Commun; 1998 Jun; 247(3):644-53. PubMed ID: 9647747 [TBL] [Abstract][Full Text] [Related]
35. Tumor angiogenesis in chronic pancreatitis and pancreatic adenocarcinoma: impact of K-ras mutations. Banerjee SK; Zoubine MN; Mullick M; Weston AP; Cherian R; Campbell DR Pancreas; 2000 Apr; 20(3):248-55. PubMed ID: 10766450 [TBL] [Abstract][Full Text] [Related]
36. Transforming growth factor-alpha-induced transcriptional activation of the vascular permeability factor (VPF/VEGF) gene requires AP-2-dependent DNA binding and transactivation. Gille J; Swerlick RA; Caughman SW EMBO J; 1997 Feb; 16(4):750-9. PubMed ID: 9049304 [TBL] [Abstract][Full Text] [Related]
37. Regulation of vascular endothelial growth factor by the Wnt and K-ras pathways in colonic neoplasia. Zhang X; Gaspard JP; Chung DC Cancer Res; 2001 Aug; 61(16):6050-4. PubMed ID: 11507052 [TBL] [Abstract][Full Text] [Related]
38. [Oncogenes and tumor suppressor genes in the signal transduction pathways of growth factors]. Buday L Orv Hetil; 1994 Nov; 135(47):2579-84. PubMed ID: 7824256 [TBL] [Abstract][Full Text] [Related]
39. Central role of p53 on regulation of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) expression in mammary carcinoma. Pal S; Datta K; Mukhopadhyay D Cancer Res; 2001 Sep; 61(18):6952-7. PubMed ID: 11559575 [TBL] [Abstract][Full Text] [Related]